Search clinical trials for: 60mcg/1.0ml recombinant hepatitis B vaccine

Total 228 results

National Heart, Lung, and Blood Institute (NHLBI)

Completed

Hepatitis B Vaccine Clinical Trial

Liver Diseases | Hepatitis B | Hepatitis, Viral, Human
University of North Carolina, Chapel Hill
Burroughs Wellcome; The American Society of Tropical Medicine and Hygiene

Completed

Evaluating Immunogenicity of a Birth Dose of HBV Vaccine in the DRC

Hepatitis B

Congo, The Democratic Republic of the
Sanofi Pasteur, a Sanofi Company

Completed

Study of the Immunogenicity and Safety of a Challenge Dose of HBVAXPRO in Healthy Children Vaccinated 10 Years Ago With 3 Doses of HEXAVAC or INFANRIX HEXA

Virus Diseases | Hepatitis B

Italy
Tehran University of Medical Sciences

Completed

Two Schedules of Hepatitis B Vaccination in Predialysis Chronic Renal Failure Patients

Renal Failure
Xiamen Innovax Biotech Co., Ltd

Completed

A Phase Ⅳ Clinical Trial of the Recombinant Hepatitis E Vaccine (Escherichia Coli)(the Chronic Hepatitis B Patients )

Hepatitis E

China
Sinovac Biotech Co., Ltd

Completed

Comparison of Immunization Schedules of Inactivated Hepatitis A Vaccine and Combined Hepatitis A and Hepatitis B Vaccine

Hepatitis B | Hepatitis A

China
Xiamen Innovax Biotech Co., Ltd
Xiamen University; Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.

Completed

A Phase Ⅳ Clinical Trial of the Recombinant Hepatitis E Vaccine (Escherichia Coli)

Hepatitis E

China
Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd

Recruiting

Safety, Tolerability, and Immunogenicity of Recombinant Meningococcal Group B Vaccine (E.Coli)

Healthy Volunteers

China
Sanofi Pasteur, a Sanofi Company

Completed

DTaP-IPV-Hep B-PRP~T Combined Vaccine Versus DTaP-IPV//PRP~T Combined Vaccine + Hep B Vaccine in Hep B Primed Infants

Hepatitis B | Pertussis | Tetanus | Diphtheria | Poliomyelitis | Haemophilus Influenzae Type b Infection

Korea, Republic of
GlaxoSmithKline

Completed

Long Term F/U Studies at Y5&6 to Demonstrate the Equivalence of 2 Vaccination Schedules of Combined Hepatitis A & B Vaccine

Hepatitis B | Hepatitis A

Australia
The Lymphoma Academic Research Organisation
Innate Pharma

Recruiting

Study of Lacutamab in Peripheral T-cell Lymphoma

Peripheral T Cell Lymphoma | Relapse/Recurrence

France, Spain, Belgium, Germany
Merck Sharp & Dohme LLC

Completed

A Hepatitis B Vaccine Challenge Study After Previous Vaxelis® Vaccination (V419-013)

Hepatitis B

Finland
Novartis Vaccines

Completed

Extension Study Evaluating Antibody Persistence and Safety, Tolerability and Immunogenicity of Booster Doses of Novartis rMenB±OMV NZ Vaccine in Healthy UK Children Who Previously Received One or Four Doses of the Same Vaccine

Meningococcal Disease

United Kingdom
Shanxi Medical University

Not yet recruiting

The Immunogenicity and Persistence of Booster Dose With Hepatitis B Vaccine in College Students

Hepatitis B Vaccine
Merck Sharp & Dohme LLC

Completed

Hepatitis B Challenge Dose in Adults (V232-059-10)

Hepatitis B
Novartis Vaccines

Completed

Safety, Tolerability and Immunogenicity of Two Different Formulations of Meningococcal B Recombinant Vaccine, When Administered to Healthy Infants

Meningococcal Disease

United Kingdom
Shaare Zedek Medical Center

Terminated

Response to Hepatitis B Vaccine in Celiac Disease Patients

Celiac Disease

Israel
Sanofi Pasteur, a Sanofi Company
GlaxoSmithKline

Completed

Study of Recombinant Protein Vaccines With Adjuvant as a Primary Series and as a Booster Dose Against COVID-19 in Adults 18 Years of Age and Older (VAT00002)

COVID-19

Honduras, United States, Australia, France, New Zealand, Spain, United Kingdom
Merck Sharp & Dohme LLC

Completed

Hepatitis B Vaccine Booster Study (V232-058)(COMPLETED)

Hepatitis B
Merck Sharp & Dohme LLC

Completed

Hepatitis B Vaccine Predialysis/Dialysis Study (V232-060)

Hepatitis B Virus Infection
Sanofi Pasteur, a Sanofi Company

Completed

Immunogenicity of DTaP-IPV-Hep B-PRP~T Combined Vaccine Compared With PENTAXIM™ and ENGERIX B® at 2-3-4 Months Schedule

Hepatitis B | Pertussis | Diphtheria | Polio

Turkey
GlaxoSmithKline

Completed

Comparison of Adjuvanted Hepatitis B Vaccine to Double Dose of Engerix™-B in Pre- /Haemodialysis Patients Aged ≥15 Years

Hepatitis B
National Institute of Allergy and Infectious Diseases...

Completed

Safety of and Immune Response to a Hepatitis B Virus Vaccine Given With a Booster (CpG7909 ODN) in HIV Infected and HIV Uninfected People

HIV Infections | Hepatitis B

United States
GlaxoSmithKline

Completed

Study to Assess the Immunological Long-term Persistence of Antibodies (Abs) 2 Years After GlaxoSmithKline (GSK) Meningococcal ABCWY Vaccination in the V102_15 (NCT02212457) and Response to a Booster in Adolescents

Infections, Meningococcal

Finland, Poland
Novartis Vaccines

Completed

Assessment of Antibody Persistence at Eighteen Months After the Completion of the Vaccination Course in Study V72P10

Meningococcal Disease | Meningococcal Meningitis

Chile
International Vaccine Institute
Bill and Melinda Gates Foundation; Xiamen Innovax Biotech Co., Ltd

Not yet recruiting

Immunogenicity and Safety of Hecolin® in HIV Positive/Negative Adults and in Children

Hepatitis E Virus Infection
U.S. Army Medical Research and Development Command
National Institute of Allergy and Infectious Diseases (NIAID); GlaxoSmithKline

Completed

A Safety and Efficacy Study of the Hepatitis E Vaccine in Nepal.

Hepatitis

Nepal
Jun Zhang
Xiamen Innovax Biotech Co., Ltd; Xiamen Center for Disease Control and Prevention

Completed

Phase Ⅳ Clinical Trial of Recombinant Hepatitis E Vaccine（Hecolin®）

Hepatitis E

China
Sanofi Pasteur, a Sanofi Company

Completed

Immunogenicity and Safety of a Quadrivalent Meningococcal Conjugate Vaccine When Administered Concomitantly With Routine Pediatric Vaccines in Healthy Infants and Toddlers in the US

Healthy Volunteers (Meningococcal Infection)

United States, Puerto Rico
University of Oxford

Completed

New Methods to Measure the Immune Response to Hepatitis B Vaccine

Hepatitis B

United Kingdom
Duke University
Centers for Disease Control and Prevention; Children's Hospital Medical Center... and other collaborators

Completed

Apnea in Hospitalized Preterm Infants Following the Administration of Routine Childhood Vaccines

Apnea | Prematurity | Apnea Neonatal

United States
Sanofi Pasteur, a Sanofi Company

Completed

Study of a Pneumococcal Conjugate Vaccine When Administered Concomitantly With Routine Pediatric Vaccines in Healthy Toddlers and Infants

Pertussis Immunisation | Diphtheria Immunisation | Tetanus Immunisation | Pneumococcal Immunisation | Hepatitis B Immunisation | Haemophilus Influenzae Type b Immunisation | Polio Immunisation | Measles Immunisation | Rubella Immunisation | Varicella Immunisation | Mumps Immunisation

United States, Canada, Honduras, Puerto Rico
Quaid-e-Azam University
Health Services Academy, Islamabad, Pakistan; Medical Research Council, Pakistan

Completed

Hepatitis B Birth Dose for Newborns (HepB-BirD)

Hepatitis B | Immunization; Infection

Pakistan
IDEWE Occupational Health Services
GlaxoSmithKline

Unknown

Twinrix Alternative Schedule Study

Antibody Response After Vaccination

Belgium
King Chulalongkorn Memorial Hospital
McGill University

Completed

Prognostic Factors in Malignant GI Bleeding Treated With Hemostatic Powder

Death

Thailand
Xiamen University
Xiamen Innovax Biotech Co., Ltd; Beijing Wantai Biological Pharmacy Enterprise...

Completed

Dose-Ranging Study of Recombinant Human Papillomavirus Virus 16/18 Bivalent Vaccine

Cervical Cancer | Cervical Intraepithelial Neoplasia

China
Dr. med. Micha Loebermann

Completed

Study to Investigate the Immune Response and Safety of Prophylactic Vaccines in Patients Treated for Multiple Sclerosis

Multiple Sclerosis, Relapsing-Remitting

Germany
Novartis Vaccines

Completed

Safety, Tolerability and Immunogenicity of Meningococcal B Recombinant Vaccine Administered With or Without Routine Infant Vaccinations to Healthy Infants According to Different Immunization Schedules

Meningococcal Infections

Belgium, Czech Republic, Germany, Italy, Spain, United Kingdom
CHA Vaccine Institute Co., Ltd.

Completed

A Study to Evaluate the Reactogenicity, Safety, and Immunogenicity of the Third Generation Hepatitis B Vaccine

Healthy
Sanofi Pasteur, a Sanofi Company

Active, not recruiting

Study of Monovalent and Bivalent Recombinant Protein Vaccines Against COVID-19 in Adults 18 Years of Age and Older (VAT00008)

COVID-19

United States, Colombia, Ghana, Honduras, India, Japan, Kenya, Mexico, Nepal, Nigeria, Sri Lanka, Uganda, Ukraine
Novartis Vaccines

Completed

Persistence of Antibody Levels and Response to Fifth or Third Meningococcal B Recombinant Vaccine in 4-year Old Healthy Children Who Previously Participated in Study V72P12E1

Meningococcal Disease | Meningococcal Meningitis

Spain, Italy, United Kingdom, Czech Republic
Novartis Vaccines

Completed

Safety, Tolerability and Immunogenicity of a Third Dose of One of Four Different Formulations of rMenB + MenACWY Combination Vaccine in Adolescents Who Previously Received the Same Study Vaccines

Meningococcal Disease | Meningococcal Meningitis

Chile, Colombia, Panama
GlaxoSmithKline
Region of Wallonia; Public Private Partnership with Institute for Medical Immunology...

Completed

Development of Read-outs in Healthy, Hepatitis B Virus Naive Adults Vaccinated With the Hepatitis B Surface Antigen (HBsAg) in Combination With a GlaxoSmithKline (GSK) Biologicals' Adjuvant System

Hepatitis B

Belgium
Dynavax Technologies Corporation

Completed

Safety of HEPLISAV™ Hepatitis B Virus Vaccine in End-stage Kidney Failure Patients

Hepatitis B

United States
GlaxoSmithKline

Completed

Long Term Follow-up Study at Years 2, 3, 4 and 5 Where 2 Dosing Schedules of the Combined Hepatitis A and B Vaccine Were Compared

Hepatitis B | Hepatitis A

Australia, Belgium, Spain
Karolinska University Hospital
Karolinska Institutet

Withdrawn

Hepatitis B in Cystic Fibrosis and Latent Tuberculosis Respectively

Hepatitis B | Hepatitis A | Tuberculosis | Cystic Fibrosis

Sweden
Millennium Pharmaceuticals, Inc.

Completed

Immune Response to Systemic and Mucosal Antigenic Challenge in the Presence of Vedolizumab

Inflammatory Bowel Disease

United Kingdom
Merck Sharp & Dohme LLC

Completed

Modified Process Hepatitis B Vaccine in Healthy Neonates (V232-056)

Hepatitis B | Hepatocellular Carcinoma
Fundación Instituto de Estudios de Ciencias de...
Instituto de Investigación Biomédica de Salamanca; Spanish Clinical Research...

Completed

Vaccination Adjuved Against Hepatitis B in SNS Workers Typed as no Responders to Conventional Vaccines

Hepatitis B | Hepatitis | Hepatitis, Viral, Human | Hepatitis B Immunization

Spain
Novartis Vaccines

Completed

A Study to Evaluate Safety and Immune Response of Novartis Meningococcal ACWY Vaccine In Infants

Meningitis, Meningococcal

United States, Argentina, Colombia

Search clinical trials for: 60mcg/1.0ml recombinant hepatitis B vaccine

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Iran

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations